McArdle C A, Forrest-Owen W
University of Bristol, Division of Medicine, UK.
J Neuroendocrinol. 1997 Dec;9(12):893-901. doi: 10.1046/j.1365-2826.1997.00657.x.
PACAP is a hypothalamic hypophysiotropic factor that acts upon a number of pituitary cells, including gonadotrophs. In the gonadotroph-derived alphaT3-1 cell line, PACAP acts via PVR1 receptors to stimulate adenylyl cyclase and phosphoinositidase C. PACAP-stimulated cAMP accumulation is inhibited by protein kinase C-activating phorbol esters in these cells and the current work was undertaken primarily to establish whether it is also subject to homologous regulation. In acute experiments, PACAP27-stimulated cAMP accumulation (intracellular plus extracellular) was measured (in the presence of phosphodiesterase inhibitor) both in intact cells and in cell membranes. The peptide increased cAMP accumulation, but initial rates of PACAP27-stimulated cAMP accumulation were reduced to between 10 and 50% within 10 min of stimulation in both cells and membranes. The initial rate of forskolin-stimulated cAMP accumulation was maintained in membranes but not in intact cells (although the deviation from linearity was less pronounced than with PACAP27). Thus, rapid homologous desensitization to PACAP27 occurs in intact alphaT3-1 cells, but is not entirely receptor specific. Rapid homologous desensitization of PACAP27-stimulated cAMP accumulation also occurred in the presence of a protein kinase C activating phorbol ester, which inhibited cAMP accumulation without altering the kinetics of the PACAP27 effect. Brief pre-treatment (3 min) with PACAP27 also reduced the ability of PACAP27, but not gonadotrophin-releasing hormone, to cause a spike-type elevation of cytosolic Ca2+ concentration (a consequence of phosphoinositidase C activation). In chronic desensitization studies, pre-treatment for 6 h with PACAP27 caused a dose-dependent (IC50 approximately 10 nM) reduction of PACAP-stimulated cAMP accumulation and down regulated cell surface PVR1 receptors (to approximately 50%). Thus, it appears that PACAP27-stimulated (PVR-1 receptor mediated) adenylyl cyclase undergoes rapid homologous desensitization in alphaT3-1 cells, which is paralleled by homologous desensitization of PACAP27-stimulated phosphoinositidase C activity and involves mechanisms distinct from those underlying heterologous desensitization by phorbol esters. Chronic desensitization of PACAP-stimulated cAMP accumulation and down-regulation of cell surface PVR-1 receptors also occurs in these cells although the receptor loss may not entirely explain the observed desensitization.
垂体腺苷酸环化酶激活肽(PACAP)是一种下丘脑促垂体因子,作用于包括促性腺激素细胞在内的多种垂体细胞。在源自促性腺激素细胞的αT3 - 1细胞系中,PACAP通过PVR1受体发挥作用,刺激腺苷酸环化酶和磷酸肌醇酶C。在这些细胞中,蛋白激酶C激活剂佛波酯可抑制PACAP刺激的环磷酸腺苷(cAMP)积累,而当前的研究主要是为了确定其是否也受到同源调节。在急性实验中,在完整细胞和细胞膜中(存在磷酸二酯酶抑制剂的情况下)测量了PACAP27刺激的cAMP积累(细胞内加细胞外)。该肽增加了cAMP积累,但在细胞和细胞膜中,PACAP27刺激的cAMP积累的初始速率在刺激后10分钟内降至10%至50%之间。在细胞膜中,福斯高林刺激的cAMP积累的初始速率得以维持,但在完整细胞中则不然(尽管与PACAP27相比,偏离线性的程度不太明显)。因此,在完整的αT3 - 1细胞中,对PACAP27会发生快速同源脱敏,但并不完全具有受体特异性。在存在蛋白激酶C激活剂佛波酯的情况下,PACAP27刺激的cAMP积累也会发生快速同源脱敏,该佛波酯抑制cAMP积累但不改变PACAP27效应的动力学。用PACAP27进行短暂预处理(3分钟)也会降低PACAP27(而非促性腺激素释放激素)引起胞质钙离子浓度尖峰型升高的能力(这是磷酸肌醇酶C激活的结果)。在慢性脱敏研究中,用PACAP27预处理6小时会导致PACAP刺激的cAMP积累呈剂量依赖性降低(半数抑制浓度约为10 nM),并使细胞表面PVR1受体下调(至约50%)。因此,似乎PACAP27刺激的(PVR - 1受体介导的)腺苷酸环化酶在αT3 - 1细胞中会发生快速同源脱敏,这与PACAP27刺激的磷酸肌醇酶C活性的同源脱敏并行,且涉及的机制与佛波酯引起的异源脱敏不同。在这些细胞中也会发生PACAP刺激的cAMP积累的慢性脱敏和细胞表面PVR - 1受体的下调,尽管受体丢失可能并不能完全解释观察到的脱敏现象。